Beyond group classification: Probabilistic differential diagnosis of frontotemporal dementia and Alzheimer’s disease with MRI and CSF biomarkers - Inria - Institut national de recherche en sciences et technologies du numérique
Article Dans Une Revue Neurobiology of Aging Année : 2024

Beyond group classification: Probabilistic differential diagnosis of frontotemporal dementia and Alzheimer’s disease with MRI and CSF biomarkers

Résumé

Neuroimaging and fluid biomarkers are used to differentiate frontotemporal dementia (FTD) from Alzheimer's disease (AD). We implemented a machine learning algorithm that provides individual probabilistic scores based on magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) data. We investigated whether combining MRI and CSF levels could improve the diagnosis confidence. 215 AD patients, 103 FTD patients, and 173 healthy controls (CTR) were studied. With MRI data, we obtained an accuracy of 82% for AD vs. FTD. A total of 74% of FTD and 73% of AD participants have a high probability of accurate diagnosis. Adding CSF-NfL and 14-3-3 levels improved the accuracy and the number of patients in the confidence group for differentiating FTD from AD. We obtain individual diagnostic probabilities with high precision to address the problem of confidence in the diagnosis. We suggest when MRI, CSF, or the combination are necessary to improve the FTD and AD diagnosis. This algorithm holds promise towards clinical applications as support to clinical findings or in settings with limited access to expert diagnoses. AD vs CTR FTD vs CTR AD vs FTD MRI all data (N=491)

Fichier principal
Vignette du fichier
2024-PerezMillan-Accepted-Manuscrit-Beyond group classification.pdf (1.88 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04851068 , version 1 (20-12-2024)

Licence

Identifiants

Citer

Agnès Pérez-Millan, Bertrand Thirion, Neus Falgàs, Sergi Borrego-Écija, Beatriz Bosch, et al.. Beyond group classification: Probabilistic differential diagnosis of frontotemporal dementia and Alzheimer’s disease with MRI and CSF biomarkers. Neurobiology of Aging, 2024, 144, pp.1-11. ⟨10.1016/j.neurobiolaging.2024.08.008⟩. ⟨hal-04851068⟩
0 Consultations
0 Téléchargements

Partager

More